Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.41
USPH's Cash-to-Debt is ranked higher than
50% of the 274 Companies
in the Global Medical Care industry.

( Industry Median: 0.28 vs. USPH: 0.41 )
Ranked among companies with meaningful Cash-to-Debt only.
USPH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.17  Med: 0.73 Max: No Debt
Current: 0.41
0.17
No Debt
Equity-to-Asset 0.50
USPH's Equity-to-Asset is ranked higher than
52% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. USPH: 0.50 )
Ranked among companies with meaningful Equity-to-Asset only.
USPH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.27  Med: 0.67 Max: 0.97
Current: 0.5
0.27
0.97
Debt-to-Equity 0.23
USPH's Debt-to-Equity is ranked higher than
72% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 0.64 vs. USPH: 0.23 )
Ranked among companies with meaningful Debt-to-Equity only.
USPH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0  Med: 0.23 Max: 2.18
Current: 0.23
0
2.18
Debt-to-EBITDA 0.73
USPH's Debt-to-EBITDA is ranked higher than
79% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 2.81 vs. USPH: 0.73 )
Ranked among companies with meaningful Debt-to-EBITDA only.
USPH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.04  Med: 0.63 Max: 0.94
Current: 0.73
0.04
0.94
Interest Coverage 3.22
USPH's Interest Coverage is ranked lower than
70% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 6.85 vs. USPH: 3.22 )
Ranked among companies with meaningful Interest Coverage only.
USPH' s Interest Coverage Range Over the Past 10 Years
Min: 2.6  Med: 53.71 Max: 140.64
Current: 3.22
2.6
140.64
Piotroski F-Score: 4
Altman Z-Score: 5.52
Beneish M-Score: -2.83
WACC vs ROIC
9.45%
14.48%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 13.08
USPH's Operating Margin % is ranked higher than
69% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 6.83 vs. USPH: 13.08 )
Ranked among companies with meaningful Operating Margin % only.
USPH' s Operating Margin % Range Over the Past 10 Years
Min: 12.72  Med: 14.16 Max: 15.71
Current: 13.08
12.72
15.71
Net Margin % 5.78
USPH's Net Margin % is ranked higher than
57% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 3.88 vs. USPH: 5.78 )
Ranked among companies with meaningful Net Margin % only.
USPH' s Net Margin % Range Over the Past 10 Years
Min: 4.82  Med: 6.03 Max: 9.06
Current: 5.78
4.82
9.06
ROE % 10.44
USPH's ROE % is ranked higher than
61% of the 255 Companies
in the Global Medical Care industry.

( Industry Median: 8.03 vs. USPH: 10.44 )
Ranked among companies with meaningful ROE % only.
USPH' s ROE % Range Over the Past 10 Years
Min: 10.36  Med: 13.59 Max: 19.88
Current: 10.44
10.36
19.88
ROA % 5.98
USPH's ROA % is ranked higher than
64% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 3.48 vs. USPH: 5.98 )
Ranked among companies with meaningful ROA % only.
USPH' s ROA % Range Over the Past 10 Years
Min: 5.78  Med: 8.75 Max: 13.79
Current: 5.98
5.78
13.79
ROC (Joel Greenblatt) % 143.23
USPH's ROC (Joel Greenblatt) % is ranked higher than
89% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 14.91 vs. USPH: 143.23 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
USPH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 73.77  Med: 120.8 Max: 149.88
Current: 143.23
73.77
149.88
3-Year Revenue Growth Rate 9.70
USPH's 3-Year Revenue Growth Rate is ranked higher than
64% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 6.50 vs. USPH: 9.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
USPH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 7.1  Med: 13.3 Max: 100.8
Current: 9.7
7.1
100.8
3-Year EBITDA Growth Rate 6.10
USPH's 3-Year EBITDA Growth Rate is ranked higher than
59% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 5.90 vs. USPH: 6.10 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
USPH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 8.25 Max: 31.7
Current: 6.1
0
31.7
3-Year EPS without NRI Growth Rate 3.90
USPH's 3-Year EPS without NRI Growth Rate is ranked lower than
58% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. USPH: 3.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
USPH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 8 Max: 57.8
Current: 3.9
0
57.8
GuruFocus has detected 8 Warning Signs with US Physical Therapy Inc USPH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» USPH's 30-Y Financials

Financials (Next Earnings Date: 2018-06-29)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2017

USPH Guru Trades in Q2 2017

Jim Simons 668,074 sh (+10.43%)
Chuck Royce 317,825 sh (unchged)
» More
Q3 2017

USPH Guru Trades in Q3 2017

Paul Tudor Jones 6,623 sh (New)
Jim Simons 708,674 sh (+6.08%)
Chuck Royce 310,882 sh (-2.18%)
» More
Q4 2017

USPH Guru Trades in Q4 2017

HOTCHKIS & WILEY 11,707 sh (New)
Paul Tudor Jones Sold Out
Chuck Royce 270,263 sh (-13.07%)
Jim Simons 594,974 sh (-16.04%)
» More
Q1 2018

USPH Guru Trades in Q1 2018

Jim Simons 624,500 sh (+4.96%)
HOTCHKIS & WILEY 11,707 sh (unchged)
Chuck Royce 270,263 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with USPH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
HOTCHKIS & WILEY 2017-12-31 New Buy$62.45 - $72.45 $ 97.9044%11,707
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621498    SIC: 8093
Compare:HKSE:03309, SAU:4007, BOM:532843, BKK:VIBHA, BKK:RAM, LSE:SPI, BOM:540975, XKLS:5878, NAS:PRSC, BKK:SVH, XSWX:AEVS, BKK:BCH, BKK:THG, ISX:SILO, SAU:4009, NAS:TVTY, NSE:NH, OHEL:TTALO, TSE:6197, ASX:PRY » details
Traded in other countries:UPH.Germany,
Headquarter Location:USA
US Physical Therapy Inc operates outpatient physical therapy and occupational therapy clinics across US which provide treatment for orthopedic disorders, sports-related injuries, and work-related injuries.

US Physical Therapy Inc operates outpatient physical therapy and occupational therapy clinics throughout the United States. Its clinics provide treatment for orthopedic disorders, sports-related injuries, and work-related injuries. The company also administers care designed to prevent injuries from occurring. At the start of 2002, the company operated 170 clinics in more than 30 states.

Ratios

vs
industry
vs
history
PE Ratio 59.69
USPH's PE Ratio is ranked lower than
79% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 27.31 vs. USPH: 59.69 )
Ranked among companies with meaningful PE Ratio only.
USPH' s PE Ratio Range Over the Past 10 Years
Min: 8.91  Med: 20.35 Max: 60.27
Current: 59.69
8.91
60.27
Forward PE Ratio 40.49
USPH's Forward PE Ratio is ranked lower than
80% of the 59 Companies
in the Global Medical Care industry.

( Industry Median: 20.66 vs. USPH: 40.49 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 59.69
USPH's PE Ratio without NRI is ranked lower than
80% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. USPH: 59.69 )
Ranked among companies with meaningful PE Ratio without NRI only.
USPH' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.91  Med: 19.8 Max: 60.27
Current: 59.69
8.91
60.27
Price-to-Owner-Earnings 34.95
USPH's Price-to-Owner-Earnings is ranked lower than
61% of the 109 Companies
in the Global Medical Care industry.

( Industry Median: 26.64 vs. USPH: 34.95 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
USPH' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.5  Med: 20.67 Max: 59.78
Current: 34.95
5.5
59.78
PB Ratio 5.94
USPH's PB Ratio is ranked lower than
81% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 2.64 vs. USPH: 5.94 )
Ranked among companies with meaningful PB Ratio only.
USPH' s PB Ratio Range Over the Past 10 Years
Min: 1.12  Med: 2.76 Max: 6
Current: 5.94
1.12
6
PS Ratio 2.95
USPH's PS Ratio is ranked lower than
65% of the 262 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. USPH: 2.95 )
Ranked among companies with meaningful PS Ratio only.
USPH' s PS Ratio Range Over the Past 10 Years
Min: 0.49  Med: 1.3 Max: 2.98
Current: 2.95
0.49
2.98
Price-to-Free-Cash-Flow 24.16
USPH's Price-to-Free-Cash-Flow is ranked lower than
53% of the 135 Companies
in the Global Medical Care industry.

( Industry Median: 23.01 vs. USPH: 24.16 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
USPH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 3.33  Med: 10.47 Max: 24.41
Current: 24.16
3.33
24.41
Price-to-Operating-Cash-Flow 21.32
USPH's Price-to-Operating-Cash-Flow is ranked lower than
69% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 14.67 vs. USPH: 21.32 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
USPH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.83  Med: 9.1 Max: 21.53
Current: 21.32
2.83
21.53
EV-to-EBIT 22.81
USPH's EV-to-EBIT is ranked higher than
50% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 21.68 vs. USPH: 22.81 )
Ranked among companies with meaningful EV-to-EBIT only.
USPH' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.9  Med: 9.4 Max: 23.03
Current: 22.81
3.9
23.03
EV-to-EBITDA 19.40
USPH's EV-to-EBITDA is ranked lower than
61% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 15.23 vs. USPH: 19.40 )
Ranked among companies with meaningful EV-to-EBITDA only.
USPH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.1  Med: 7.9 Max: 19.59
Current: 19.4
3.1
19.59
EV-to-Revenue 3.03
USPH's EV-to-Revenue is ranked lower than
61% of the 271 Companies
in the Global Medical Care industry.

( Industry Median: 2.17 vs. USPH: 3.03 )
Ranked among companies with meaningful EV-to-Revenue only.
USPH' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.5  Med: 1.4 Max: 2.9
Current: 3.03
0.5
2.9
PEG Ratio 7.99
USPH's PEG Ratio is ranked lower than
84% of the 97 Companies
in the Global Medical Care industry.

( Industry Median: 3.13 vs. USPH: 7.99 )
Ranked among companies with meaningful PEG Ratio only.
USPH' s PEG Ratio Range Over the Past 10 Years
Min: 0.83  Med: 3.11 Max: 7.99
Current: 7.99
0.83
7.99
Shiller PE Ratio 63.70
USPH's Shiller PE Ratio is ranked lower than
73% of the 62 Companies
in the Global Medical Care industry.

( Industry Median: 31.76 vs. USPH: 63.70 )
Ranked among companies with meaningful Shiller PE Ratio only.
USPH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 11.61  Med: 26.93 Max: 64.31
Current: 63.7
11.61
64.31
Current Ratio 1.67
USPH's Current Ratio is ranked higher than
73% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. USPH: 1.67 )
Ranked among companies with meaningful Current Ratio only.
USPH' s Current Ratio Range Over the Past 10 Years
Min: 1.63  Med: 4.57 Max: 42
Current: 1.67
1.63
42
Quick Ratio 1.67
USPH's Quick Ratio is ranked higher than
75% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.24 vs. USPH: 1.67 )
Ranked among companies with meaningful Quick Ratio only.
USPH' s Quick Ratio Range Over the Past 10 Years
Min: 1.63  Med: 4.57 Max: 42
Current: 1.67
1.63
42
Days Sales Outstanding 39.72
USPH's Days Sales Outstanding is ranked lower than
60% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 39.87 vs. USPH: 39.72 )
Ranked among companies with meaningful Days Sales Outstanding only.
USPH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 39.41  Med: 42.69 Max: 52.02
Current: 39.72
39.41
52.02
Days Payable 1.89
USPH's Days Payable is ranked lower than
98% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 40.58 vs. USPH: 1.89 )
Ranked among companies with meaningful Days Payable only.
USPH' s Days Payable Range Over the Past 10 Years
Min: 1.89  Med: 3.03 Max: 3.86
Current: 1.89
1.89
3.86

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.88
USPH's Dividend Yield % is ranked lower than
79% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 1.79 vs. USPH: 0.88 )
Ranked among companies with meaningful Dividend Yield % only.
USPH' s Dividend Yield % Range Over the Past 10 Years
Min: 0.31  Med: 1.2 Max: 1.74
Current: 0.88
0.31
1.74
Dividend Payout Ratio 0.62
USPH's Dividend Payout Ratio is ranked higher than
77% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 0.43 vs. USPH: 0.62 )
Ranked among companies with meaningful Dividend Payout Ratio only.
USPH' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.2  Med: 0.31 Max: 0.62
Current: 0.62
0.2
0.62
3-Year Dividend Growth Rate 18.60
USPH's 3-Year Dividend Growth Rate is ranked higher than
73% of the 85 Companies
in the Global Medical Care industry.

( Industry Median: 8.70 vs. USPH: 18.60 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
USPH' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 19.3
Current: 18.6
0
19.3
Forward Dividend Yield % 0.93
USPH's Forward Dividend Yield % is ranked lower than
76% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 1.99 vs. USPH: 0.93 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 2.02
USPH's 5-Year Yield-on-Cost % is ranked lower than
55% of the 325 Companies
in the Global Medical Care industry.

( Industry Median: 2.24 vs. USPH: 2.02 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
USPH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.71  Med: 2.76 Max: 4
Current: 2.02
0.71
4
3-Year Average Share Buyback Ratio -0.90
USPH's 3-Year Average Share Buyback Ratio is ranked higher than
96% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. USPH: -0.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
USPH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -56.9  Med: -0.9 Max: 7.7
Current: -0.9
-56.9
7.7

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.82
USPH's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
58% of the 101 Companies
in the Global Medical Care industry.

( Industry Median: 1.98 vs. USPH: 1.82 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
USPH' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.39  Med: 0.98 Max: 9.21
Current: 1.82
0.39
9.21
Price-to-Intrinsic-Value-DCF (Earnings Based) 4.52
USPH's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
85% of the 33 Companies
in the Global Medical Care industry.

( Industry Median: 1.81 vs. USPH: 4.52 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
USPH' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.51  Med: 1.05 Max: 3.75
Current: 4.52
0.51
3.75
Price-to-Median-PS-Value 2.23
USPH's Price-to-Median-PS-Value is ranked lower than
92% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. USPH: 2.23 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
USPH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.46  Med: 1.12 Max: 7.63
Current: 2.23
0.46
7.63
Price-to-Peter-Lynch-Fair-Value 7.42
USPH's Price-to-Peter-Lynch-Fair-Value is ranked lower than
93% of the 55 Companies
in the Global Medical Care industry.

( Industry Median: 2.08 vs. USPH: 7.42 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
USPH' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.47  Med: 1.61 Max: 7.49
Current: 7.42
0.47
7.49
Earnings Yield (Greenblatt) % 4.41
USPH's Earnings Yield (Greenblatt) % is ranked higher than
60% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 3.61 vs. USPH: 4.41 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
USPH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.37  Med: 10.6 Max: 25.9
Current: 4.41
4.37
25.9
Forward Rate of Return (Yacktman) % 11.54
USPH's Forward Rate of Return (Yacktman) % is ranked higher than
59% of the 133 Companies
in the Global Medical Care industry.

( Industry Median: 9.10 vs. USPH: 11.54 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
USPH' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 10.6  Med: 14.95 Max: 26.9
Current: 11.54
10.6
26.9

More Statistics

Revenue (TTM) (Mil) $424.83
EPS (TTM) $ 1.64
Beta0.94
Volatility18.23%
52-Week Range $56.50 - 99.10
Shares Outstanding (Mil)12.67

Analyst Estimate

Dec18 Dec19
Revenue (Mil $) 452 491
EBIT (Mil $)
EBITDA (Mil $) 60 68
EPS ($) 2.42 2.72
EPS without NRI ($) 2.42 2.72
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.00%
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 44
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}